Charles Flexner

Also affiliated with Johns Hopkins Medicine

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus”.

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Clinical Infectious Diseases(2021)10.1093/cid/ciab212

N/A

1.5DataRank · unranked

61 citations

Carlee Moser, Christina Gavegnano, Steven G. Deeks, Michael M. Lederman, Edgar T. Overton +14 more

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

Clinical Infectious Diseases(2023)10.1093/cid/ciad199

N/A

0.732DataRank · unranked

25 citations

Carey L. Shive, Zhengyi Chen, Curtis Tatsuoka, Emily Bowman, Chris T. Longenecker +17 more

What Clinicians Need to Know About the Development of Long-Acting Formulations

Clinical Infectious Diseases(2022)10.1093/cid/ciac749

N/A

0.360DataRank · unranked

10 citations

David L. Thomas, Polly Clayden, Susan Swindells, Charles Flexner

Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries

Clinical Infectious Diseases(2024)10.1093/cid/ciae269

N/A

0.241DataRank · unranked

4 citations

Cissy Kityo, Michael D. Hughes, Caitlyn McCarthy, Carole L. Wallis, Mina C. Hosseinipour +28 more

Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments

Clinical Infectious Diseases(2021)10.1093/cid/ciab913

N/A

0DataRank · unranked

9 citations

Jacqueline Astemborski, Gregory D. Kirk, Mark Sulkowski, Stephanie Katz, Richard E. Rothman +12 more

Supramolecular nanomedicines through rational design of self-assembling prodrugs

Trends in Pharmacological Sciences(2022)10.1016/j.tips.2022.03.003

N/A

0DataRank · unranked

42 citations

Maya K. Monroe, Faith Leslie, Charles Flexner, Honggang Cui, Han Wang

Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.06.037

N/A

0DataRank · unranked

30 citations

Han Wang, Caleb F. Anderson, Hongpeng Jia, Charles Flexner, Honggang Cui +1 more

Antiviral supramolecular polymeric hydrogels by self-assembly of tenofovir-bearing peptide amphiphiles

Biomaterials Science(2022)10.1039/d2bm01649d

N/A

0DataRank · unranked

13 citations

Han Wang, Caleb F. Anderson, Meng Qin, Chloe L. Thio, Charles Flexner +2 more

Transitioning Long-Acting Products to a Generic Marketplace: What's Missing?

Clinical Infectious Diseases(2022)10.1093/cid/ciac753

N/A

0DataRank · unranked

9 citations

Kelly K. Catlin, Linda Lewis, Danielle Resar, Carolyn Amole, Robert C. Bollinger +2 more

The LEAP Process: Streamlining the Development of Long-Acting Products and Formulations for Infectious Diseases

Clinical Infectious Diseases(2022)10.1093/cid/ciac750

N/A

0DataRank · unranked

7 citations

Marco Siccardi, Fazila Bunglawala, Andrew Owen, Charles Flexner

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

The Lancet HIV(2023)10.1016/s2352-3018(22)00365-4

N/A

0DataRank · unranked

64 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver +32 more

Constructing Antiretroviral Supramolecular Polymers as Long-Acting Injectables through Rational Design of Drug Amphiphiles with Alternating Antiretroviral-Based and Hydrophobic Residues

Journal of the American Chemical Society(2023)10.1021/jacs.3c05645

N/A

0DataRank · unranked

11 citations

Maya K. Monroe, Feihu Wang, Mingjiao Sun, Charles Flexner, Honggang Cui +1 more

Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans

Pharmaceutics(2023)10.3390/pharmaceutics15122709

N/A

0DataRank · unranked

7 citations

Rajith K. R. Rajoli, Henry Pertinez, Lalitkumar K. Vora, Fabiana Volpe‐Zanutto, Ryan F. Donnelly +5 more

Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations

Pharmaceutics(2023)10.3390/pharmaceutics15071835

N/A

0DataRank · unranked

6 citations

J. Hobson, Neill J. Liptrott, Edward Makarov, Amer Al‐khouja, Lee Tatham +12 more

Polymer–prodrug conjugates as candidates for degradable, long-acting implants, releasing the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine

Journal of Materials Chemistry B(2023)10.1039/d3tb02268d

N/A

0DataRank · unranked

1 citations

Faye Y. Hern, A. Shakil, Kartik Temburnikar, Pierre Chambon, Neill J. Liptrott +7 more

Current Challenges, Solutions, and Novel Directions in Research and Clinical Care: Proceedings From the 14th Annual International Workshop on HIV and Aging

The Journals of Gerontology Series A(2024)10.1093/gerona/glae259

N/A

0DataRank · unranked

1 citations

Sarah Cooley, Moka Yoo‐Jeong, Beau M. Ances, Gustavo Duque, Ronald J. Ellis +10 more

Hyaluronidase impacts exposures of long-acting injectable paliperidone palmitate in rodent models

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.03.583160

N/A

0DataRank · unranked

2 citations

Amit Kaushik, Paul Curley, Usman Arshad, Eman El‐Khateeb, Si‐Yang Li +11 more

Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357

Clinical Infectious Diseases(2025)10.1093/cid/ciaf375

N/A

0DataRank · unranked

5 citations

Yu Zheng, Katherine Rodríguez, Leah Burke, Jacqueline D. Reeves, Kimberly K. Scarsi +46 more

Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

The Lancet HIV(2025)10.1016/s2352-3018(25)00162-6

N/A

0DataRank · unranked

3 citations

Caitlyn McCarthy, Carole L. Wallis, Cissy Kityo, Michael D. Hughes, Catherine Godfrey +44 more

Investigations of Long-Acting Formulations in Children, Adolescents, and Pregnant Women: A Systematic Review

Pharmaceutics(2025)10.3390/pharmaceutics17010113

N/A

0DataRank · unranked

2 citations

Zhengyi Deng, Melissa Davy-Rothwell, Elaine J. Abrams, Charles Flexner, Ethel D. Weld +1 more

Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic Enhancement

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf319

N/A

0DataRank · unranked

1 citations

Charles Flexner, Zachary R. Stephen, Edward P. Acosta, Rachel Bender Ignacio, Rodney J. Y. Ho +1 more

Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf270

N/A

0DataRank · unranked

1 citations

Caitlyn McCarthy, Serena P. Koenig, Michael D Hughes, Carole L. Wallis, Isaac Tsikhutsu +41 more

Structure–Activity Relationship Studies of Emtricitabine Prodrugs toward Long-Acting Antiretroviral Formulations

ACS Omega(2025)10.1021/acsomega.5c03319

N/A

0DataRank · unranked

0 citations

Stephanie Henriquez, J. Hobson, Jennifer A. White, Charles Flexner, Andrew Owen +3 more

Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2099

N/A

0DataRank · unranked

27 citations

David Back, Charles Flexner, Peter Sjö, Terrence F. Blaschke, Peter Horby +5 more

Current Challenges, Solutions, and Novel Directions in Research and Clinical Care: Proceedings from the 14th Annual International Workshop on HIV and Aging

UNC Libraries(2025)10.17615/rpve-am53

N/A

0DataRank · unranked

0 citations

Jing Sun, John D. Mullins, April D. Thames, Abigail Baim‐Lance, Joseph B. Margolick +10 more

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?

Clinical Infectious Diseases(2020)10.1093/cid/ciaa691

N/A

0DataRank · unranked

5 citations

Charles Flexner, Matthew M. Ippolito

Comparison of Once‐Daily versus Twice‐Daily Combination Antiretroviral Therapy in Treatment‐Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48‐Week Randomized Controlled Trial

UNC Libraries(2020)10.17615/msnd-sd43

N/A

0DataRank · unranked

0 citations

Robert A. Gross, Camlin Tierney, Angela D. M. Kashuba, Elaine Ferguson, Christina M. Lalama +10 more

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

The Lancet Global Health(2021)10.1016/s2214-109x(21)00025-5

N/A

0DataRank · unranked

75 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Peter Ehrenkranz, Celicia Serenata, François Venter +6 more